Introduction {#sec1-1}
============

Cholangiocarcinoma accounts for 3% of gastrointestinal malignancies.\[[@ref1][@ref2]\] Median age of presentation is the 7^th^ decade.\[[@ref2]\] Occurrence of cholangiocarcinoma in a pregnant patient is uncommon, with few reported cases.\[[@ref3][@ref4][@ref5][@ref6][@ref7]\] Here we present a postpartum patient with cholangiocarcinoma.

Case Presentation {#sec1-2}
=================

A 28-year-old lady presented with 1 week of high-grade fever on postpartum day 10. She had right upper abdominal pain and jaundice from week 20 of gestation. She had postprandial vomiting throughout pregnancy. She underwent regular antenatal checkups and fetal ultrasound scans during this pregnancy. Provisional diagnosis of acute fatty liver of pregnancy (AFLP) was made by her treating physician. She delivered via normal vaginal delivery at week 33. Abdominal distention, initially attributed to pregnancy, worsened after delivery. There was no loss of weight, melena, pruritus, or pale stools. She denied history of smoking, diabetes mellitus, hypertension, and malignancy in family members. Due to worsening symptoms she was referred to our hospital for evaluation.

On examination, her pulse rate was 122/min and temperature 101F. Systemic examination revealed a hard liver palpable 12 cm below the right costal margin. Shifting dullness was present. Pelvic examination was normal.

Differential diagnoses considered were infectious causes (liver abscess, malaria, endometritis) and non-infectious etiologies (Budd Chiari syndrome, AFLP). Neoplastic etiology was also considered due to chronic history of jaundice and abdominal pain. Blood investigations have been mentioned in [Table 1](#T1){ref-type="table"}. Ascitic fluid analysis revealed 240 cells/ml (neutrophils-24%, lymphocytes-76%), albumin and protein of 1.4 g/dl and 3.1 g/dl, respectively. Blood, urine, and ascitic fluid cultures did not reveal growth. Computed tomography (CT) scan showed hepatomegaly with multiple liver lesions, largest being 13 × 10 × 8 cm. Multiple lung nodules, enlarged lesser omental, para-aortic, aortocaval lymph nodes, and lytic lesion in the first lumbar vertebra were noted.

###### 

Relevant laboratory investigations

  Test                               Patient's Values   Reference Range
  ---------------------------------- ------------------ -----------------
  Hemoglobin (gram/dl)               8.5                11-15
  Total Leucocyte Count (mm^3^)      13,400             4,400-11,000/µL
   Neutrophils                       84                 40-70%
   Lymphocytes                       8                  20-40%
   Monocytes                         8                  2-6%
  Platelets                          3,42,000           1.5-4.5 lacs/µL
  Creatinine (mg/dL)                 0.52               0.5-1.4
  Total bilirubin (mg/dl)            0.50               0.5-1
  Direct bilirubin                   0.35               0.5-1
  SGOT (U/L)                         48                 8-40
  SGPT (U/L)                         31                 5-35
  Alkaline phosphatase (U/L)         302                40-125
  Total protein (gram/dl)            5.9                6-8.5
  Albumin (gram/dl)                  2.1                3.5-5
  Gamma-glutamyl transferase (U/L)   106                \<55
  Beta-HCG (mIU/ml)                  11                 \<5
  Carcinoembryonic Antigen           11.5               \<5
  Alpha-fetoprotein (IU/ml)          29.6               \<5
  HIV 1 and 2 antibodies             Non-reactive       
  Hepatitis B surface antigen        Negative           
  Hepatitis C antibody               Negative           

Ultrasound-guided biopsy of the largest liver lesion was done. This was reported as cholangiocarcinoma \[[Figure 1](#F1){ref-type="fig"}\]. Our final diagnosis was metastatic intrahepatic cholangiocarcinoma. Our patient was initiated on palliative chemotherapy with capecitabine and opted for follow-up at another center.

![Photomicrograph depicting infiltrating malignant tumor glands (black arrow) of cholangiocarcinoma (400×, H and E)](JFMPC-8-3748-g001){#F1}

Discussion {#sec1-3}
==========

Common causes of postpartum fever include endometritis, urinary tract infection, mastitis, and perineal/episiotomy site infections.\[[@ref8][@ref9]\] Cholangiocarcinoma presenting as postpartum fever is rare.\[[@ref10]\]

Risk factors for cholangiocarcinoma include primary sclerosing cholangitis, hepatobiliary flukes, bile duct cystic disorders, cirrhosis, diabetes mellitus, and obesity.\[[@ref11][@ref12][@ref13][@ref14][@ref15][@ref16]\] Our patient was a 28-year-old female without any risk factors for cholangiocarcinoma.

In our patient, ascitic fluid analysis was consistent with malignant ascites (low-serum ascites albumin gradient, high-ascitic fluid protein). Fever, though uncommon, has been reported in other cases of cholangiocarcinoma.\[[@ref17][@ref18]\]

Abdominal pain and jaundice are common symptoms of cholangiocarcinoma.\[[@ref19]\] Clinical presentation of cholangiocarcinoma can mimic that of AFLP and HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) \[[Table 2](#T2){ref-type="table"}\].\[[@ref4][@ref6]\]

###### 

Cholangiocarcinoma diagnosed in pregnancy/postpartum period

  Clinical Features                                                           Case 1 (Qasrawi *et al.*\[[@ref4]\])                       Case 2 (Balderston *et al.*\[[@ref6]\])                                   Case 3 (Goswami *et al.*\[[@ref7]\])
  --------------------------------------------------------------------------- ---------------------------------------------------------- ------------------------------------------------------------------------- -----------------------------------------------------------------------------------
  Age                                                                         38                                                         23                                                                        22
  Obstetric history                                                           4^th^ pregnancy                                            Primigravida                                                              NA
  Symptoms and duration                                                       RUQ pain, dark urine - one week                            Vomiting, abdominal pain^&^                                               Abdominal pain, weight loss, fever-three weeks
  Gestation in weeks at symptom onset                                         36                                                         26                                                                        2 weeks post-partum
  Abnormal examination findings                                               Palpable liver, jaundice                                   RUQ mass, jaundice, new onset high blood pressure                         RUQ mass, jaundice
  Onset of jaundice                                                           36 weeks of gestation                                      26 weeks of gestation                                                     2 weeks postpartum
  Laboratory investigations (Reference range):                                                                                                                                                                     
  Total bilirubin in mg/dL (0.5-1)                                            6.4                                                        3.6→5.1                                                                   17.3
  Direct bilirubin in mg/dL                                                   5                                                          NA                                                                        10.5
  Aspartate Aminotransferase in Units/L (8-40)                                83                                                         70                                                                        95
  Alanine Aminotransferase in Units/L (5-35)                                  87                                                         31                                                                        70
  Alkaline Phosphatase in Units/L (40-125)                                    319                                                        NA                                                                        680
  Prothrombin Time with International Normalized ratio in seconds (11-13.5)   17 and 1.4                                                 NA and 1.8                                                                NA
  Imaging:                                                                                                                                                                                                         
  Ultrasound                                                                  Hepatomegaly with liver mass                               Liver mass lesion                                                         Dilated CBD with filling defect
  Computed Tomography                                                         NA                                                         NA                                                                        Intramural lesions in CBD, cystic duct, gall bladder; dilated gallbladder and CBD
  Magnetic Resonance Imaging                                                  Mass lesions in the liver; intrahepatic biliary dilation   NA                                                                        NA
  Endoscopic Retrograde Cholangio-Pancreatography                             Not done                                                   Right sided hepatic tumor; constriction of right biliary system and CBD   Dilated CBD with obstruction
  Final Diagnosis                                                             Intrahepatic cholangiocarcinoma                            Intrahepatic cholangiocarcinoma                                           Biliary intraductal neoplasm
  Outcome                                                                     Died 6 months after diagnosis                              Died 3 weeks after diagnosis                                              NA

^&^Symptom duration not available; NA-Details not available; CBD-Common Bile Duct; RUQ-right upper quadrant

In our patient, pregnancy could have masked hepatomegaly and ascites and led to delay in establishing diagnosis.

Antenatal ultrasound scans focus on fetal parameters and may not detect maternal visceral abnormalities. CT scans are contraindicated in pregnancy. Tumor markers like alpha-fetoprotein and alkaline phosphatase are elevated in normal pregnancies. Weight loss due to malignancy may not occur in a pregnant patient. Vomiting due to other causes may be attributed to pregnancy. The above factors lead to difficulty in diagnosis of malignancy in a pregnant patient.

A significant proportion of antenatal checkups are conducted by primary care and family medicine physicians. Jaundice in pregnancy is associated with maternal complications and high maternal and perinatal mortality rates.\[[@ref20]\] At primary care level, pregnant patients with jaundice should be referred to higher centers as they require multidisciplinary approach.\[[@ref21]\]

Conclusion {#sec1-4}
==========

Though rare, cholangiocarcinoma can occur in pregnancy and postpartum state.

Symptoms and signs of a neoplastic process maybe masked during pregnancy.

Low index of suspicion and limited diagnostic modalities may prevent early diagnosis of malignancy in pregnant women.

Declaration of patient consent {#sec2-1}
------------------------------

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship {#sec2-2}
---------------------------------

Nil.

Conflicts of interest {#sec2-3}
---------------------

There are no conflicts of interest.

None.
